Equity Overview
Price & Market Data
Price: $0.52
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $31,579,130
Daily Volume: 0
Performance Metrics
1 Week: 4.00%
1 Month: 4.00%
3 Months: 4.00%
6 Months: 4.00%
1 Year: -65.33%
YTD: 4.00%
Company Details
Employees: 1
Sector: Distribution services
Industry: Food distributors
Country:
Details
Revium Rx, a pre-clinical stage biopharmaceutical company, develops nano-liposomal particles (NLP) based pharmaceutical candidates. It develops nanoparticles-based formulation of a potent antibiotic; novel adjuvant for cancer therapies: and novel immunization based on liposomal protein-loaded technology. The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024. Revium Rx was incorporated in 1997 and is based in Herzliya, Israel.